Myc down-regulation as a mechanism to activate the Rb pathway in STAT5A-induced senescence

被引:41
作者
Mallette, Frederick A. [1 ]
Gaumont-Leclerc, Marie-France [1 ]
Huot, Genevieve [1 ]
Ferbeyre, Gerardo [1 ]
机构
[1] Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada
关键词
D O I
10.1074/jbc.M707074200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Senescence is a general antiproliferative program that avoids the expansion of cells bearing oncogenic mutations. We found that constitutively active STAT5A (ca-STAT5A) can induce a p53- and Rb-dependent cellular senescence response. However, ca-STAT5A did not induce p21 and p16(INK4a), which are responsible for inhibiting cyclin-dependent protein kinases and engaging the Rb pathway during the senescence response to oncogenic ras. Intriguingly, ca-STAT5A led to a down-regulation of Myc and Myc targets, including CDK4, a negative regulator of Rb. The down-regulation of Myc was in part proteasome-dependent and correlated with its localization to promyelocytic leukemia bodies, which were found to be highly abundant during STAT5-induced senescence. Introduction of CDK4 or Myc bypassed STAT5A-induced senescence in cells in which p53 was also inactivated. These results uncover a novel mechanism to engage the Rb pathway in oncogene-induced senescence and indicate the existence of oncogene-specific pathways that regulate senescence.
引用
收藏
页码:34938 / 34944
页数:7
相关论文
共 56 条
[1]
Stat5 in the mammary gland: Controlling normal development and cancer [J].
Barash, Itamar .
JOURNAL OF CELLULAR PHYSIOLOGY, 2006, 209 (02) :305-313
[2]
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints [J].
Bartkova, Jirina ;
Rezaei, Nousin ;
Liontos, Michalis ;
Karakaidos, Panagiotis ;
Kletsas, Dimitris ;
Issaeva, Natalia ;
Vassiliou, Leandros-Vassilios F. ;
Kolettas, Evangelos ;
Niforou, Katerina ;
Zoumpourlis, Vassilis C. ;
Takaoka, Munenori ;
Nakagawa, Hiroshi ;
Tort, Frederic ;
Fugger, Kasper ;
Johansson, Fredrik ;
Sehested, Maxwell ;
Andersen, Claus L. ;
Dyrskjot, Lars ;
Orntoft, Torben ;
Lukas, Jiri ;
Kittas, Christos ;
Helleday, Thomas ;
Halazonetis, Thanos D. ;
Bartek, Jiri ;
Gorgoulis, Vassilis G. .
NATURE, 2006, 444 (7119) :633-637
[3]
A BLOCK TO ELONGATION IS LARGELY RESPONSIBLE FOR DECREASED TRANSCRIPTION OF C-MYC IN DIFFERENTIATED HL60 CELLS [J].
BENTLEY, DL ;
GROUDINE, M .
NATURE, 1986, 321 (6071) :702-706
[4]
A genetic screen to identify genes that rescue the slow growth phenotype of c-myc null fibroblasts [J].
Berns, K ;
Hijmans, EM ;
Koh, E ;
Daley, GQ ;
Bernards, R .
ONCOGENE, 2000, 19 (29) :3330-3334
[5]
STATs in oncogenesis [J].
Bowman, T ;
Garcia, R ;
Turkson, J ;
Jove, R .
ONCOGENE, 2000, 19 (21) :2474-2488
[6]
The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor β-induced growth inhibition that is inactivated in pancreatic cancer [J].
Buck, Anita ;
Buchholz, Malte ;
Wagner, Martin ;
Adler, Guido ;
Gress, Thomas ;
Ellenrieder, Volker .
MOLECULAR CANCER RESEARCH, 2006, 4 (11) :861-872
[7]
PML4 induces differentiation by Myc destabilization [J].
Buschbeck, M. ;
Uribesalgo, I. ;
Ledl, A. ;
Gutierrez, A. ;
Minucci, S. ;
Muller, S. ;
Di Croce, L. .
ONCOGENE, 2007, 26 (23) :3415-3422
[8]
PML interacts with Myc, and Myc target gene expression is altered in PML-null fibroblasts [J].
Cairo, S ;
De Falco, F ;
Pizzo, M ;
Salomoni, P ;
Pandolfi, PP ;
Meroni, G .
ONCOGENE, 2005, 24 (13) :2195-2203
[9]
Pocket proteins and cell cycle control [J].
Cobrinik, D .
ONCOGENE, 2005, 24 (17) :2796-2809
[10]
Stat5a is tyrosine phosphorylated and nuclear localized in a high proportion of human breast cancers [J].
Cotarla, I ;
Ren, SX ;
Zhang, Y ;
Gehan, E ;
Singh, B ;
Furth, PA .
INTERNATIONAL JOURNAL OF CANCER, 2004, 108 (05) :665-671